Report cover image

Global Radiopharmaceuticals for Diagnosis Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 204 Pages
SKU # APRC20283047

Description

Summary

According to APO Research, The global Radiopharmaceuticals for Diagnosis market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Radiopharmaceuticals for Diagnosis include Atom High-tech Co., Ltd., Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory, Tianjin Said Biopharmaceutical Co., Ltd., Shenzhen Larven Bioengineering Technology Co., Ltd., Shanghai Atom Kexing Pharmaceutical Co., Ltd., Shanghai Xinke Pharmaceutical Co., Ltd., Ningbo Jun'an Pharmaceutical Technology Co., Ltd., Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. and Guangdong Xi'ai Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Radiopharmaceuticals for Diagnosis, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Radiopharmaceuticals for Diagnosis, also provides the sales of main regions and countries. Of the upcoming market potential for Radiopharmaceuticals for Diagnosis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Radiopharmaceuticals for Diagnosis sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Radiopharmaceuticals for Diagnosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Radiopharmaceuticals for Diagnosis sales, projected growth trends, production technology, application and end-user industry.

Radiopharmaceuticals for Diagnosis Segment by Company

Atom High-tech Co., Ltd.
Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
Tianjin Said Biopharmaceutical Co., Ltd.
Shenzhen Larven Bioengineering Technology Co., Ltd.
Shanghai Atom Kexing Pharmaceutical Co., Ltd.
Shanghai Xinke Pharmaceutical Co., Ltd.
Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
Guangdong Xi'ai Pharmaceutical Co., Ltd.
Chengdu Zhonghe Gaotong Isotope Co., Ltd.
Chengdu Yunke Pharmaceutical Co., Ltd.
Chengdu Xinke Pharmaceutical Co., Ltd.
Beijing Zhibo High-tech Biotechnology Co., Ltd.
RadioMedix, Inc.
PDRadiopharma Inc.
Lantheus
Jubilant Radiopharma
GE Healthcare Ltd
DOE IP
Radiopharmaceuticals for Diagnosis Segment by Type

Strontium [89Sr] Chloride
Sodium Iodide [131I]
Iodine [125I] Sealed Seed Source
Technetium [99mTc] Pentetate
Technetium [99mTc] Polymerized Albumin
Technetium [99mTc] Dithiodithiocarbamate
Other
Radiopharmaceuticals for Diagnosis Segment by Application

Hospital
Clinic
Other
Radiopharmaceuticals for Diagnosis Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals for Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals for Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals for Diagnosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Radiopharmaceuticals for Diagnosis in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Radiopharmaceuticals for Diagnosis manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiopharmaceuticals for Diagnosis sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

204 Pages
1 Market Overview
1.1 Product Definition
1.2 Radiopharmaceuticals for Diagnosis Market by Type
1.2.1 Global Radiopharmaceuticals for Diagnosis Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Strontium [89Sr] Chloride
1.2.3 Sodium Iodide [131I]
1.2.4 Iodine [125I] Sealed Seed Source
1.2.5 Technetium [99mTc] Pentetate
1.2.6 Technetium [99mTc] Polymerized Albumin
1.2.7 Technetium [99mTc] Dithiodithiocarbamate
1.2.8 Other
1.3 Radiopharmaceuticals for Diagnosis Market by Application
1.3.1 Global Radiopharmaceuticals for Diagnosis Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Radiopharmaceuticals for Diagnosis Market Dynamics
2.1 Radiopharmaceuticals for Diagnosis Industry Trends
2.2 Radiopharmaceuticals for Diagnosis Industry Drivers
2.3 Radiopharmaceuticals for Diagnosis Industry Opportunities and Challenges
2.4 Radiopharmaceuticals for Diagnosis Industry Restraints
3 Global Market Growth Prospects
3.1 Global Radiopharmaceuticals for Diagnosis Revenue Estimates and Forecasts (2020-2031)
3.2 Global Radiopharmaceuticals for Diagnosis Revenue by Region
3.2.1 Global Radiopharmaceuticals for Diagnosis Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Radiopharmaceuticals for Diagnosis Revenue by Region (2020-2025)
3.2.3 Global Radiopharmaceuticals for Diagnosis Revenue by Region (2026-2031)
3.2.4 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2020-2031)
3.3 Global Radiopharmaceuticals for Diagnosis Sales Estimates and Forecasts 2020-2031
3.4 Global Radiopharmaceuticals for Diagnosis Sales by Region
3.4.1 Global Radiopharmaceuticals for Diagnosis Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Radiopharmaceuticals for Diagnosis Sales by Region (2020-2025)
3.4.3 Global Radiopharmaceuticals for Diagnosis Sales by Region (2026-2031)
3.4.4 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Radiopharmaceuticals for Diagnosis Revenue by Manufacturers
4.1.1 Global Radiopharmaceuticals for Diagnosis Revenue by Manufacturers (2020-2025)
4.1.2 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Radiopharmaceuticals for Diagnosis Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Radiopharmaceuticals for Diagnosis Sales by Manufacturers
4.2.1 Global Radiopharmaceuticals for Diagnosis Sales by Manufacturers (2020-2025)
4.2.2 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Radiopharmaceuticals for Diagnosis Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Radiopharmaceuticals for Diagnosis Sales Price by Manufacturers (2020-2025)
4.4 Global Radiopharmaceuticals for Diagnosis Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Radiopharmaceuticals for Diagnosis Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Radiopharmaceuticals for Diagnosis Manufacturers, Product Type & Application
4.7 Global Radiopharmaceuticals for Diagnosis Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Radiopharmaceuticals for Diagnosis Market CR5 and HHI
4.8.2 2024 Radiopharmaceuticals for Diagnosis Tier 1, Tier 2, and Tier 3
5 Radiopharmaceuticals for Diagnosis Market by Type
5.1 Global Radiopharmaceuticals for Diagnosis Revenue by Type
5.1.1 Global Radiopharmaceuticals for Diagnosis Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Radiopharmaceuticals for Diagnosis Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2020-2031)
5.2 Global Radiopharmaceuticals for Diagnosis Sales by Type
5.2.1 Global Radiopharmaceuticals for Diagnosis Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Radiopharmaceuticals for Diagnosis Sales by Type (2020-2031) & (K Units)
5.2.3 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2020-2031)
5.3 Global Radiopharmaceuticals for Diagnosis Price by Type
6 Radiopharmaceuticals for Diagnosis Market by Application
6.1 Global Radiopharmaceuticals for Diagnosis Revenue by Application
6.1.1 Global Radiopharmaceuticals for Diagnosis Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Radiopharmaceuticals for Diagnosis Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2020-2031)
6.2 Global Radiopharmaceuticals for Diagnosis Sales by Application
6.2.1 Global Radiopharmaceuticals for Diagnosis Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Radiopharmaceuticals for Diagnosis Sales by Application (2020-2031) & (K Units)
6.2.3 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2020-2031)
6.3 Global Radiopharmaceuticals for Diagnosis Price by Application
7 Company Profiles
7.1 Atom High-tech Co., Ltd.
7.1.1 Atom High-tech Co., Ltd. Comapny Information
7.1.2 Atom High-tech Co., Ltd. Business Overview
7.1.3 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
7.1.5 Atom High-tech Co., Ltd. Recent Developments
7.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
7.2.1 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Comapny Information
7.2.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Business Overview
7.2.3 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolio
7.2.5 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments
7.3 Tianjin Said Biopharmaceutical Co., Ltd.
7.3.1 Tianjin Said Biopharmaceutical Co., Ltd. Comapny Information
7.3.2 Tianjin Said Biopharmaceutical Co., Ltd. Business Overview
7.3.3 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
7.3.5 Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments
7.4 Shenzhen Larven Bioengineering Technology Co., Ltd.
7.4.1 Shenzhen Larven Bioengineering Technology Co., Ltd. Comapny Information
7.4.2 Shenzhen Larven Bioengineering Technology Co., Ltd. Business Overview
7.4.3 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
7.4.5 Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments
7.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd.
7.5.1 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Comapny Information
7.5.2 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Business Overview
7.5.3 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
7.5.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments
7.6 Shanghai Xinke Pharmaceutical Co., Ltd.
7.6.1 Shanghai Xinke Pharmaceutical Co., Ltd. Comapny Information
7.6.2 Shanghai Xinke Pharmaceutical Co., Ltd. Business Overview
7.6.3 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
7.6.5 Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments
7.7 Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
7.7.1 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Comapny Information
7.7.2 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Business Overview
7.7.3 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
7.7.5 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments
7.8 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
7.8.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Comapny Information
7.8.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Business Overview
7.8.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
7.8.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments
7.9 Guangdong Xi'ai Pharmaceutical Co., Ltd.
7.9.1 Guangdong Xi'ai Pharmaceutical Co., Ltd. Comapny Information
7.9.2 Guangdong Xi'ai Pharmaceutical Co., Ltd. Business Overview
7.9.3 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
7.9.5 Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments
7.10 Chengdu Zhonghe Gaotong Isotope Co., Ltd.
7.10.1 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Comapny Information
7.10.2 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Business Overview
7.10.3 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
7.10.5 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments
7.11 Chengdu Yunke Pharmaceutical Co., Ltd.
7.11.1 Chengdu Yunke Pharmaceutical Co., Ltd. Comapny Information
7.11.2 Chengdu Yunke Pharmaceutical Co., Ltd. Business Overview
7.11.3 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
7.11.5 Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments
7.12 Chengdu Xinke Pharmaceutical Co., Ltd.
7.12.1 Chengdu Xinke Pharmaceutical Co., Ltd. Comapny Information
7.12.2 Chengdu Xinke Pharmaceutical Co., Ltd. Business Overview
7.12.3 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
7.12.5 Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments
7.13 Beijing Zhibo High-tech Biotechnology Co., Ltd.
7.13.1 Beijing Zhibo High-tech Biotechnology Co., Ltd. Comapny Information
7.13.2 Beijing Zhibo High-tech Biotechnology Co., Ltd. Business Overview
7.13.3 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
7.13.5 Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments
7.14 RadioMedix, Inc.
7.14.1 RadioMedix, Inc. Comapny Information
7.14.2 RadioMedix, Inc. Business Overview
7.14.3 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
7.14.5 RadioMedix, Inc. Recent Developments
7.15 PDRadiopharma Inc.
7.15.1 PDRadiopharma Inc. Comapny Information
7.15.2 PDRadiopharma Inc. Business Overview
7.15.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
7.15.5 PDRadiopharma Inc. Recent Developments
7.16 Lantheus
7.16.1 Lantheus Comapny Information
7.16.2 Lantheus Business Overview
7.16.3 Lantheus Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Lantheus Radiopharmaceuticals for Diagnosis Product Portfolio
7.16.5 Lantheus Recent Developments
7.17 Jubilant Radiopharma
7.17.1 Jubilant Radiopharma Comapny Information
7.17.2 Jubilant Radiopharma Business Overview
7.17.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolio
7.17.5 Jubilant Radiopharma Recent Developments
7.18 GE Healthcare Ltd
7.18.1 GE Healthcare Ltd Comapny Information
7.18.2 GE Healthcare Ltd Business Overview
7.18.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolio
7.18.5 GE Healthcare Ltd Recent Developments
7.19 DOE IP
7.19.1 DOE IP Comapny Information
7.19.2 DOE IP Business Overview
7.19.3 DOE IP Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 DOE IP Radiopharmaceuticals for Diagnosis Product Portfolio
7.19.5 DOE IP Recent Developments
8 North America
8.1 North America Radiopharmaceuticals for Diagnosis Market Size by Type
8.1.1 North America Radiopharmaceuticals for Diagnosis Revenue by Type (2020-2031)
8.1.2 North America Radiopharmaceuticals for Diagnosis Sales by Type (2020-2031)
8.1.3 North America Radiopharmaceuticals for Diagnosis Price by Type (2020-2031)
8.2 North America Radiopharmaceuticals for Diagnosis Market Size by Application
8.2.1 North America Radiopharmaceuticals for Diagnosis Revenue by Application (2020-2031)
8.2.2 North America Radiopharmaceuticals for Diagnosis Sales by Application (2020-2031)
8.2.3 North America Radiopharmaceuticals for Diagnosis Price by Application (2020-2031)
8.3 North America Radiopharmaceuticals for Diagnosis Market Size by Country
8.3.1 North America Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Radiopharmaceuticals for Diagnosis Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Radiopharmaceuticals for Diagnosis Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Radiopharmaceuticals for Diagnosis Market Size by Type
9.1.1 Europe Radiopharmaceuticals for Diagnosis Revenue by Type (2020-2031)
9.1.2 Europe Radiopharmaceuticals for Diagnosis Sales by Type (2020-2031)
9.1.3 Europe Radiopharmaceuticals for Diagnosis Price by Type (2020-2031)
9.2 Europe Radiopharmaceuticals for Diagnosis Market Size by Application
9.2.1 Europe Radiopharmaceuticals for Diagnosis Revenue by Application (2020-2031)
9.2.2 Europe Radiopharmaceuticals for Diagnosis Sales by Application (2020-2031)
9.2.3 Europe Radiopharmaceuticals for Diagnosis Price by Application (2020-2031)
9.3 Europe Radiopharmaceuticals for Diagnosis Market Size by Country
9.3.1 Europe Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Radiopharmaceuticals for Diagnosis Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Radiopharmaceuticals for Diagnosis Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Radiopharmaceuticals for Diagnosis Market Size by Type
10.1.1 China Radiopharmaceuticals for Diagnosis Revenue by Type (2020-2031)
10.1.2 China Radiopharmaceuticals for Diagnosis Sales by Type (2020-2031)
10.1.3 China Radiopharmaceuticals for Diagnosis Price by Type (2020-2031)
10.2 China Radiopharmaceuticals for Diagnosis Market Size by Application
10.2.1 China Radiopharmaceuticals for Diagnosis Revenue by Application (2020-2031)
10.2.2 China Radiopharmaceuticals for Diagnosis Sales by Application (2020-2031)
10.2.3 China Radiopharmaceuticals for Diagnosis Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Radiopharmaceuticals for Diagnosis Market Size by Type
11.1.1 Asia Radiopharmaceuticals for Diagnosis Revenue by Type (2020-2031)
11.1.2 Asia Radiopharmaceuticals for Diagnosis Sales by Type (2020-2031)
11.1.3 Asia Radiopharmaceuticals for Diagnosis Price by Type (2020-2031)
11.2 Asia Radiopharmaceuticals for Diagnosis Market Size by Application
11.2.1 Asia Radiopharmaceuticals for Diagnosis Revenue by Application (2020-2031)
11.2.2 Asia Radiopharmaceuticals for Diagnosis Sales by Application (2020-2031)
11.2.3 Asia Radiopharmaceuticals for Diagnosis Price by Application (2020-2031)
11.3 Asia Radiopharmaceuticals for Diagnosis Market Size by Country
11.3.1 Asia Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Radiopharmaceuticals for Diagnosis Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Radiopharmaceuticals for Diagnosis Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Radiopharmaceuticals for Diagnosis Market Size by Type
12.1.1 SAMEA Radiopharmaceuticals for Diagnosis Revenue by Type (2020-2031)
12.1.2 SAMEA Radiopharmaceuticals for Diagnosis Sales by Type (2020-2031)
12.1.3 SAMEA Radiopharmaceuticals for Diagnosis Price by Type (2020-2031)
12.2 SAMEA Radiopharmaceuticals for Diagnosis Market Size by Application
12.2.1 SAMEA Radiopharmaceuticals for Diagnosis Revenue by Application (2020-2031)
12.2.2 SAMEA Radiopharmaceuticals for Diagnosis Sales by Application (2020-2031)
12.2.3 SAMEA Radiopharmaceuticals for Diagnosis Price by Application (2020-2031)
12.3 SAMEA Radiopharmaceuticals for Diagnosis Market Size by Country
12.3.1 SAMEA Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Radiopharmaceuticals for Diagnosis Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Radiopharmaceuticals for Diagnosis Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Radiopharmaceuticals for Diagnosis Value Chain Analysis
13.1.1 Radiopharmaceuticals for Diagnosis Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Radiopharmaceuticals for Diagnosis Production Mode & Process
13.2 Radiopharmaceuticals for Diagnosis Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Radiopharmaceuticals for Diagnosis Distributors
13.2.3 Radiopharmaceuticals for Diagnosis Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.